1 al model of lipid peroxidation consisting of
orogastric administration of CCl4 to rats was used.
2 e were fed a low-phosphate diet (LPD) before
orogastric administration of ethanol.
3 Orogastric administration of fatty acids elevated blood
4 Orogastric administration of virstatin protects infant m
5 the effect of DeltatoxRS in vivo using a new
orogastric adult murine model of colonization.
6 To our knowledge, the
orogastric adult murine model reported here is the first
7 B cells and antibodies, were as resistant to
orogastric and disseminated candidiasis of endogenous or
8 the IL-1 receptor were highly susceptible to
orogastric but not intraperitoneal infection with Salmon
9 Although highly susceptible to
orogastric candidiasis, T-cell receptor delta- and alpha
10 r IL-4 deficiency enhanced susceptibility to
orogastric candidiasis.
11 KO, and wild-type (immunocompetent) mice to
orogastric candidiasis.
12 th different combinations of sterile saline,
orogastric contaminants, and methylene blue were incubat
13 It is postulated that
orogastric contamination of the intragastric balloon may
14 enuated LT adjuvant (LTK63) by intranasal or
orogastric delivery, induced high antigen-specific serum
15 Enteral nutrition with a nasogastric/
orogastric feeding tube is essential in premature infant
16 (GC-C-/-) were administered C. rodentium by
orogastric gavage and analyzed at multiple time points u
17 technique, during which mice received daily
orogastric gavage with either UDCA or vehicle only.
18 ium and perish shortly after epicutaneous or
orogastric infection respectively.
19 d that neonatal mice are highly resistant to
orogastric infection with Yersinia enterocolitica.
20 ness of glpT-deficient mutants during murine
orogastric infection.
21 the alimentary tract, and reduced numbers of
orogastric infections demonstrated not only that probiot
22 Rats were given an
orogastric infusion (0.25 ml) of either AF or 0.9% salin
23 0.0, 0.01, or 0.03 microg, in saline) and an
orogastric infusion of 0.25 ml amniotic fluid or saline
24 ctamase were administered 24 and 12 h before
orogastric inoculation of piperacillin-resistant pathoge
25 taeae(860-939) as a vaccine was evaluated by
orogastric inoculation of rabbits with RDEC-1Deltaeae(86
26 After
orogastric inoculation of VRE, clindamycin-treated mice
27 e liver and spleen of susceptible mice after
orogastric inoculation.
28 ociated lymph tissues of the mouse following
orogastric inoculation.
29 failed to survive in the cecum of mice after
orogastric inoculation.
30 nogenic in mice following intranasal but not
orogastric inoculation.
31 In an
orogastric model of Y. pseudotuberculosis infection, a D
32 to be free of H. pylori were vaccinated with
orogastric (
n = 4) or intramuscular (n = 5) urease.
33 le suspension (two 40-mg doses on day 1, via
orogastric or nasogastric tube, and 40 mg each day there
34 to impact the virulence of this organism in
orogastric or systemic infection models.
35 stem with murine neonates, using the natural
orogastric route of transmission for the enteropathogen
36 By contrast, infection by the
orogastric route resulted in limited infection and seroc
37 tonometer was placed in the stomach via the
orogastric route.
38 ssion of mouse beta -defensins (mBDs) 1-4 in
orogastric tissues from germ-free (gf) and Candida albic
39 levels of beta -defensin gene expression in
orogastric tissues from gf mice varied significantly bet
40 wth velocity, decreased transition time from
orogastric to breast feeds, and increased postprandial m
41 Both groups were given ciprofloxacin by
orogastric tube twice daily for 14 days, beginning 1-2 h
42 [11C]methylphenidate administered through an
orogastric tube.
43 l status, 35% dysphagia, and 27% nasogastric/
orogastric tubes.
44 High-dose
orogastric vaccination with M. microti resulted in a sta
45 ceptibilities of 7-day-old and adult mice to
orogastric Y. enterocolitica infection were assessed in